Morgan Stanley Regeneron Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,185,488 shares of REGN stock, worth $847 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,185,488

Previous 1,341,298 11.62%

Holding current value

$847 Million

Previous $1.41 Billion 11.6%

% of portfolio

0.09%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $160 Million - $187 Million	-155,810 Reduced 11.62%	1,185,488 $1.25 Billion
Q2 2024 Oct 17, 2024	BUY	$883.2 - $1071.19 $1.59 Million - $1.93 Million	1,799 Added 0.13%	1,341,298 $1.41 Billion
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.59 Million - $1.93 Million	1,799 Added 0.13%	1,341,298 $1.41 Billion
Q1 2024 Oct 17, 2024	SELL	$902.69 - $993.35 $1.62 Million - $1.79 Million	-1,799 Reduced 0.13%	1,339,499 $1.29 Billion
Q1 2024 Aug 16, 2024	BUY	$902.69 - $993.35 $181 Million - $199 Million	199,980 Added 17.55%	1,339,499 $1.29 Billion
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $181 Million - $199 Million	199,980 Added 17.55%	1,339,499 $1.29 Billion
Q4 2023 Aug 16, 2024	SELL	$775.18 - $881.7 $156 Million - $178 Million	-201,779 Reduced 15.04%	1,139,519 $1 Billion
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $131 Million - $149 Million	168,562 Added 17.36%	1,139,519 $1 Billion
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $17.9 Million - $21.8 Million	25,792 Added 2.73%	970,957 $799 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $23 Million - $27.3 Million	32,889 Added 3.61%	945,165 $679 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $15.6 Million - $18.9 Million	22,898 Added 2.57%	912,276 $750 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $62.9 Million - $68.3 Million	89,081 Added 11.13%	889,378 $642 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $24.3 Million - $30.6 Million	42,253 Added 5.57%	800,297 $551 Million
Q2 2022 Oct 27, 2022	BUY	$548.35 - $738.84 $164 Million - $221 Million	299,537 Added 65.33%	758,044 $448 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $164 Million - $221 Million	299,537 Added 65.33%	758,044 $448 Million
Q1 2022 Oct 27, 2022	SELL	$595.12 - $698.43 $178 Million - $209 Million	-299,537 Reduced 39.51%	458,507 $320 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $46.1 Million - $54.1 Million	-77,525 Reduced 14.46%	458,507 $320 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $22.5 Million - $27.7 Million	41,339 Added 8.36%	536,032 $339 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $284 Million - $337 Million	494,693 New	494,693 $299 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account